MODIFICATION
A -- LAWRENCE LIVERMORE NATIONAL LABORATORY ANNOUNCES OPPORTUNITY FOR DEVELOPMENT OF LASER-COMPTON X-RAY SYSTEMS
- Notice Date
- 8/27/2013
- Notice Type
- Modification/Amendment
- NAICS
- 238990
— All Other Specialty Trade Contractors
- Contracting Office
- Department of Energy, Lawrence Livermore National Laboratory (DOE Contractor), Industrial Partnerships & Commercialization, 7000 East Avenue, L-795, Livermore, California, 94550
- ZIP Code
- 94550
- Solicitation Number
- FBO276-13
- Archive Date
- 9/30/2013
- Point of Contact
- Connie L Pitcock, Phone: 925-422-1072
- E-Mail Address
-
pitcock1@llnl.gov
(pitcock1@llnl.gov)
- Small Business Set-Aside
- N/A
- Description
- LAWRENCE LIVERMORE NATIONAL LABORATORY ANNOUNCES OPPORTUNITY FOR DEVELOPMENT OF LASER-COMPTON X-RAY SYSTEMS Opportunity : Lawrence Livermore National Laboratory (LLNL) operated by the Lawrence Livermore National Security, LLC (LLNS) under contract no. DE-AC52-07NA27344 (Contract 44) with the U.S. Department of Energy (DOE), is a national security laboratory managed as a government-owned, contractor-operated (GOCO), federally funded research and development center (FFRDC). LLNL seeks a commercial partner for collaborative research and development oF laser-compton x-ray systems. LLNL expertise and capabilities are available on an exclusive basis subject to DOE requirements and priorities, and subject to complementary research interests with LLNL. Background: Over the past decade LLNL has both invented new concepts for and led the world in the development of laser-based, mono-energetic, high-energy, photon sources based on laser-Compton scattering. These sources, which combine high-energy, high-average-power lasers and compact, high-gradient, RF-accelerator technology promise to transform traditional industrial and medical x-ray applications. Project Description: The selected industrial partner and LLNL will enter into a Cooperative Research and Development Agreement (CRADA) to develop the next generation of laser technologies for laser-Compton x-ray systems and to create a next generation of compact, laser-Compton x-ray sources that could be marketed to both the industrial, medical and academic communities. The laser-Compton system developed will be based on LLNL's proprietary, multi-GHz Compton scattering interaction geometry, multi-GHz, photo-gun drive laser technology, hyper-dispersion short pulse laser architectures and kW-average-power, diode-pumped pulsed laser technology. The resulting integrated laser-Compton x-ray source will be both compact and unique in the world with respect to flux, source size and spectral purity of the output. This system will target emerging medical, business and science opportunities worldwide. The successful execution of this CRADA will enable the U.S. to establish industrial leadership in several key laser, accelerator and x-ray technology areas. It is anticipated that the activity will also increase U.S. competitiveness internationally in the areas of compact accelerator technology. At the conclusion of the CRADA project, the industrial partner will have the right to license from LLNL any associated pre-existing laser-Compton-related intellectual property as well as any laser-Compton-related laser, x-ray, accelerator and detector intellectual property generated during the course of the CRADA activity. Advantages: The technology research and development associated with this machine will provide the basis for developing production machines for clinical environments, research facilities and mobile or re-locatable machines that could be deployed for field exploration. At the conclusion of this CRADA, the LLNL laser-Compton x-ray capability will be ready for initial medical research studies. Potential Applications: This CRADA will provide new tools that will enhance the U.S. ability to domestically diagnose and treat disease and will enable precision x-ray radiographic inspection for U.S. industries and domestic industrial applications. The unique source size (10 to 100x smaller than conventional sources), source collimation (100,000 to 1,000,000x more collimated than conventional sources) and the ability to produce quasi-mono-energetic output are transformational and enable; ultra-high spatial resolution imaging with extremely low dose to the object, multi-angle therapeutic x-ray modalities with enhanced deposition of dose on target and deployment of new and more efficient detector technologies. Furthermore, successful execution of this CRADA will provide the necessary capability to develop follow-on, higher-energy x-ray and gamma-ray sources that may lead to new methods for isotope-specific radiography and radiology. Development Status: LLNL's proprietary laser-compton x-ray technology is described in the following intellectual property: U. S. Patent No. 7,564,241 - Isotopic Imaging Via Nuclear Resonance Fluorescence with Laser-Based Thomson Radiation ; U.S. Patent No. 8,068,522- Hyper-Dispersion Pulse Compressor for Chirped Pulse Amplification Systems; U.S. Patent No. 8,369,480 - Dual Isotope Notch Observer for Isotope Identification, Assay and Imaging with Mono-Energetic Gamma-Ray Sources; U.S. Patent Application No. PCT/US/25/51806 Isotope-Specific Arbitrary Material Sorter; U.S. Patent Application No.61/526124 Isotope-Specific Material Flow Meter; U.S. Patent Application No. 13/552610 - High Flux, Narrow Bandwidth Compton Light Sources via Extend Laser-Electron Interactions; and Patent Application No. PCT/US/12/54872 - Source of Directly-Synchronized, Multi-Gigahertz, Sub-Picosecond Optical Pulses There is also an additional half-dozen cases being filed. Areas for Respondent Feedback: Note: THIS IS NOT A PROCUREMENT. Respondents to this opportunity must describe specific capabilities, attributes, and skills directly related to the following areas. Required Criteria: 1. Company Name, address, telephone number, and website 2. The name, telephone number, email address of a point of contact 3. Description of corporate related experience, expertise, capabilities relevant to the commercial laser systems market 4. Experience related to design and construction of compact, energetic laser technology and associated control systems. 5. Demonstrated ability to bring innovations to the market 7. Interest in performing and/or funding cooperative research at the LLNL 8. Sufficient resources and experience to accomplish deployment and commercialization 9. Relevance for LLNL's mission and economic development interests 10. Substantial manufacturing and operations presence in the United States Optional Criteria: 1. Experience in working with Federal Government CRADA agreements 2. Knowledge of U.S. Federal Export Control rules and regulations. Please provide your written statement within thirty (30) days from the date this announcement is published to ensure consideration of your interest in LLNL's Laser-Compton X-Ray Systems technology collaborative research, development and business opportunity. Please visit the IPO website at: https://ipo.llnl.gov/?q=resources-industry-working_with_us for more information on working with LLNL and the industrial partnering and technology transfer process. Responses should be submitted by September 27, 2013, via e-mail directed to: Business Development Executive Catherine Elizondo elizondo1@llnl.gov Or Business Development Associate Connie Pitcock pitcock1@llnl.gov Attention: FBO 276-13
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DOE/LLNL/LL/FBO276-13/listing.html)
- Record
- SN03163420-W 20130829/130827234957-28a9f15128d8e2fb017521ba64c2e513 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |